| 肺癌血管生成的新理解 |
| |
| 引用本文： | 申海霁,陆舜. 肺癌血管生成的新理解[J]. 世界临床药物, 2008, 29(10): 606-612 |
| |
| 作者姓名： | 申海霁 陆舜 |
| |
| 作者单位： | 上海交通大学附属胸科医院肺部肿瘤临床医学中心;上海交通大学附属胸科医院肺部肿瘤临床医学中心 |
| |
| 摘 要： | 肺癌是全世界最常见的恶性肿瘤之一.近年来,抑制肿瘤血管生成的分子靶向治疗为肺癌提供了新的治疗手段.许多研究不仅使人们对肿瘤血管生成有了新的理解,还提出了新的治疗靶点和方法.本文总结该类别系列药物的开发,并指出其可能对临床治疗的影响.
|
| 关 键 词： | 肺癌 血管生成 抑制 分子靶向治疗 |
Latest understanding of angiogenesis on lung cancer |
| |
| SHEN Hai-Ji,LU Shun. Latest understanding of angiogenesis on lung cancer[J]. WORLD CLINICAL DRUGS, 2008, 29(10): 606-612 |
| |
| Authors: | SHEN Hai-Ji LU Shun |
| |
| Affiliation: | SHEN Hai-Ji,LU Shun (Shanghai Lung Tumor Clinic Medicine Center,Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University,Shanghai 200030,China) |
| |
| Abstract: | Lung cancer is one of the most common malignancies in the world.It is proposed that molecular targeted therapies such as antiangiogenesis contribute a new therapeutic method on lung cancer recently.Many recent discoveries have the potential not only to suggest some of the latest understanding on tumor angiogenesis but also to indicate new therapeutic targets and treatment strategies.The purpose of this review is to summarize a number of these discoveries and to point out their potential clinical impact. |
| |
| Keywords: | lung cancer angiogenesis inhibit molecular targeted therapy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
